Aldosterone-to-renin ratio for diagnosing aldosterone-producing adenoma: A multicentre study

Summary Background Biological diagnostic criteria for diagnosing aldosterone-producing adenoma (APA) are not well-established. Aim The aim of the study was to establish the best biological predictors of APA. Methods A prospective register was implemented in 17 secondary or tertiary hypertension cent...

Full description

Saved in:
Bibliographic Details
Published inArchives of cardiovascular diseases Vol. 105; no. 12; pp. 623 - 630
Main Authors Ducher, Michel, Mounier-Véhier, Claire, Baguet, Jean-Philippe, Tartière, Jean-Michel, Sosner, Philippe, Régnier-Le Coz, Sylvie, Perez, Laurence, Fourcade, Jacques, Jabourek, Olivier, Lejeune, Sylvain, Stolz, Arnaud, Fauvel, Jean-Pierre
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier Masson SAS 01.12.2012
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Summary Background Biological diagnostic criteria for diagnosing aldosterone-producing adenoma (APA) are not well-established. Aim The aim of the study was to establish the best biological predictors of APA. Methods A prospective register was implemented in 17 secondary or tertiary hypertension centres. The inclusion criterion was one of the following: onset of hypertension before 40 years of age; history of hypokalaemia; drug-resistant hypertension (resistant to three drugs); or spironolactone efficiency on BP. Results Among the 338 collected cases, 192 patients had two aldosterone-to-renin ratio (ARR) determinations (after 1 hour supine and at least 1 hour upright) on the same occasion. Twenty-five patients (8.2%) had biological hyperaldosteronism and an adrenal adenoma identified by computed tomography. APA was histologically confirmed in all 12 patients who underwent surgery. Histologically proven APAs were used as the ‘gold standard’ in receiver operating characteristic (ROC) curve analysis. ARRs were computed with a minimum renin value set at 5 ng/L to avoid misclassification of so-called ‘low-renin hypertension’. To predict an APA, the ARR area under the ROC curve was 0.93. A supine ARR cut-off value of 32 ng/ng provided the highest sum of sensitivity (92%) plus specificity (92%). On the basis of an ARR ≥ 32 ng/ng in the supine and/or upright position, sensitivity reached 100%. Conclusion The proposed cut-off value of 32 ng/ng for ARR (minimum renin value set at 5 ng/L) in one of two determinations had 100% sensitivity and 72% specificity with 20% positive and 100% negative predictive values for diagnosing APA.
AbstractList Biological diagnostic criteria for diagnosing aldosterone-producing adenoma (APA) are not well-established. The aim of the study was to establish the best biological predictors of APA. A prospective register was implemented in 17 secondary or tertiary hypertension centres. The inclusion criterion was one of the following: onset of hypertension before 40 years of age; history of hypokalaemia; drug-resistant hypertension (resistant to three drugs); or spironolactone efficiency on BP. Among the 338 collected cases, 192 patients had two aldosterone-to-renin ratio (ARR) determinations (after 1hour supine and at least 1hour upright) on the same occasion. Twenty-five patients (8.2%) had biological hyperaldosteronism and an adrenal adenoma identified by computed tomography. APA was histologically confirmed in all 12 patients who underwent surgery. Histologically proven APAs were used as the ‘gold standard’ in receiver operating characteristic (ROC) curve analysis. ARRs were computed with a minimum renin value set at 5ng/L to avoid misclassification of so-called ‘low-renin hypertension’. To predict an APA, the ARR area under the ROC curve was 0.93. A supine ARR cut-off value of 32ng/ng provided the highest sum of sensitivity (92%) plus specificity (92%). On the basis of an ARR≥32ng/ng in the supine and/or upright position, sensitivity reached 100%. The proposed cut-off value of 32ng/ng for ARR (minimum renin value set at 5ng/L) in one of two determinations had 100% sensitivity and 72% specificity with 20% positive and 100% negative predictive values for diagnosing APA. Les critères biologiques pour le diagnostic d’un adénome de Conn ne sont pas bien établi. L’objectif de cette étude est d’établir les seuils biologiques d’aldostérone et de rénine permettant de prédire un adénome de Conn. Un registre prospectif a été mis en œuvre dans 17 centres de l’hypertension. Le critère d’inclusion dans le registre était l’un des éléments suivants : apparition de l’hypertension avant 40ans, antécédent d’hypokaliémie, hypertension artérielle résistante ou efficacité trop importante de la spironolactone dans le traitement de l’hypertension. Parmi les 338 cas recueillis, 192 patients ont eu deux déterminations successives de rénine et d’aldostérone (une heure en position couchée et au moins une heure debout). Vingt-cinq patients (8,2 %) avaient un hyperaldostéronisme biologique et un adénome surrénalien identifié par une tomodensitométrie. Une histologie compatible avec un adénome de Conn a été confirmée chez les les 12 patients qui ont été opérés. Un adénome de Conn histologiquement confirmé a été utilisé comme « gold standard » pour l’établissement des courbes ROC. Les rapports aldostérone/rénine (RAR) ont été calculés avec une valeur minimale de rénine fixée à 5ng/L. Afin de prédire un adénome de Conn, l’aire sous la courbe ROC du RAR était de 0,93. Une valeur de RAR couchée supérieure à 32ng/ng avait les sensibilités (92 %) et spécificité (92 %) les plus élevées. Sur la base d’un RAR supérieur à 32ng/ng en décubitus dorsal et/ou en orthostatisme, la sensibilité atteint 100 %. Le seuil de RAR à 32ng/ng (valeur minimale de rénine à 5ng/L) lors de l’une des deux déterminations, soit en décubitus dorsal, soit en orthostatisme a une sensibilité de 100 %, une spécificité de 72 %, une valeur prédictive positive de 20 % et une valeur prédictive négative de 100 % pour le diagnostic d’un adénome de Conn.
BACKGROUNDBiological diagnostic criteria for diagnosing aldosterone-producing adenoma (APA) are not well-established.AIMThe aim of the study was to establish the best biological predictors of APA.METHODSA prospective register was implemented in 17 secondary or tertiary hypertension centres. The inclusion criterion was one of the following: onset of hypertension before 40 years of age; history of hypokalaemia; drug-resistant hypertension (resistant to three drugs); or spironolactone efficiency on BP.RESULTSAmong the 338 collected cases, 192 patients had two aldosterone-to-renin ratio (ARR) determinations (after 1 hour supine and at least 1 hour upright) on the same occasion. Twenty-five patients (8.2%) had biological hyperaldosteronism and an adrenal adenoma identified by computed tomography. APA was histologically confirmed in all 12 patients who underwent surgery. Histologically proven APAs were used as the 'gold standard' in receiver operating characteristic (ROC) curve analysis. ARRs were computed with a minimum renin value set at 5 ng/L to avoid misclassification of so-called 'low-renin hypertension'. To predict an APA, the ARR area under the ROC curve was 0.93. A supine ARR cut-off value of 32ng/ng provided the highest sum of sensitivity (92%) plus specificity (92%). On the basis of an ARR≥32 ng/ng in the supine and/or upright position, sensitivity reached 100%.CONCLUSIONThe proposed cut-off value of 32 ng/ng for ARR (minimum renin value set at 5 ng/L) in one of two determinations had 100% sensitivity and 72% specificity with 20% positive and 100% negative predictive values for diagnosing APA.
Biological diagnostic criteria for diagnosing aldosterone-producing adenoma (APA) are not well-established. The aim of the study was to establish the best biological predictors of APA. A prospective register was implemented in 17 secondary or tertiary hypertension centres. The inclusion criterion was one of the following: onset of hypertension before 40 years of age; history of hypokalaemia; drug-resistant hypertension (resistant to three drugs); or spironolactone efficiency on BP. Among the 338 collected cases, 192 patients had two aldosterone-to-renin ratio (ARR) determinations (after 1 hour supine and at least 1 hour upright) on the same occasion. Twenty-five patients (8.2%) had biological hyperaldosteronism and an adrenal adenoma identified by computed tomography. APA was histologically confirmed in all 12 patients who underwent surgery. Histologically proven APAs were used as the 'gold standard' in receiver operating characteristic (ROC) curve analysis. ARRs were computed with a minimum renin value set at 5 ng/L to avoid misclassification of so-called 'low-renin hypertension'. To predict an APA, the ARR area under the ROC curve was 0.93. A supine ARR cut-off value of 32ng/ng provided the highest sum of sensitivity (92%) plus specificity (92%). On the basis of an ARR≥32 ng/ng in the supine and/or upright position, sensitivity reached 100%. The proposed cut-off value of 32 ng/ng for ARR (minimum renin value set at 5 ng/L) in one of two determinations had 100% sensitivity and 72% specificity with 20% positive and 100% negative predictive values for diagnosing APA.
Summary Background Biological diagnostic criteria for diagnosing aldosterone-producing adenoma (APA) are not well-established. Aim The aim of the study was to establish the best biological predictors of APA. Methods A prospective register was implemented in 17 secondary or tertiary hypertension centres. The inclusion criterion was one of the following: onset of hypertension before 40 years of age; history of hypokalaemia; drug-resistant hypertension (resistant to three drugs); or spironolactone efficiency on BP. Results Among the 338 collected cases, 192 patients had two aldosterone-to-renin ratio (ARR) determinations (after 1 hour supine and at least 1 hour upright) on the same occasion. Twenty-five patients (8.2%) had biological hyperaldosteronism and an adrenal adenoma identified by computed tomography. APA was histologically confirmed in all 12 patients who underwent surgery. Histologically proven APAs were used as the ‘gold standard’ in receiver operating characteristic (ROC) curve analysis. ARRs were computed with a minimum renin value set at 5 ng/L to avoid misclassification of so-called ‘low-renin hypertension’. To predict an APA, the ARR area under the ROC curve was 0.93. A supine ARR cut-off value of 32 ng/ng provided the highest sum of sensitivity (92%) plus specificity (92%). On the basis of an ARR ≥ 32 ng/ng in the supine and/or upright position, sensitivity reached 100%. Conclusion The proposed cut-off value of 32 ng/ng for ARR (minimum renin value set at 5 ng/L) in one of two determinations had 100% sensitivity and 72% specificity with 20% positive and 100% negative predictive values for diagnosing APA.
Author Jabourek, Olivier
Sosner, Philippe
Régnier-Le Coz, Sylvie
Fauvel, Jean-Pierre
Tartière, Jean-Michel
Mounier-Véhier, Claire
Lejeune, Sylvain
Perez, Laurence
Baguet, Jean-Philippe
Fourcade, Jacques
Ducher, Michel
Stolz, Arnaud
Author_xml – sequence: 1
  fullname: Ducher, Michel
– sequence: 2
  fullname: Mounier-Véhier, Claire
– sequence: 3
  fullname: Baguet, Jean-Philippe
– sequence: 4
  fullname: Tartière, Jean-Michel
– sequence: 5
  fullname: Sosner, Philippe
– sequence: 6
  fullname: Régnier-Le Coz, Sylvie
– sequence: 7
  fullname: Perez, Laurence
– sequence: 8
  fullname: Fourcade, Jacques
– sequence: 9
  fullname: Jabourek, Olivier
– sequence: 10
  fullname: Lejeune, Sylvain
– sequence: 11
  fullname: Stolz, Arnaud
– sequence: 12
  fullname: Fauvel, Jean-Pierre
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26669554$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/23199617$$D View this record in MEDLINE/PubMed
BookMark eNp9kU1r3DAQhkVJaT7aP9BD8aXQi119WJIdSmEJSVsI9NDmFhBaaRy0saVEkgP77yN3N2nooScN4nlnhmeO0YEPHhB6T3BDMBGfN402D7ahmNAGywZj8QodkU7ymhLaHTzXTByi45Q2BaBSijfokDLS94LII3S9Gm1IGWJpXedQR_DOV1FnF6ohxMo6feNDcv6m0i_IuxjsbP78WvBh0qfVqprmMTsDPkeoUp7t9i16Pegxwbv9e4KuLs5_n32vL39--3G2uqwNxzLXPdeDpmwAXRYWHQjSgdbQD7jDgnNBicSUacJ6xnDbi3Ur1xZ4P0gDayM7doI-7fqWte5nSFlNLhkYR-0hzEkRSknHMWvbgtIdamJIKcKg7qKbdNwqgtViVW3UYlUtVhWWqkgroQ_7_vN6AvscedJYgI97QCejxyFqb1z6ywkhes6X6V92HBQbDw6iSsaBN2BdBJOVDe7_e3z9J25G512ZeAtbSJswR188K6JSyahfy_2X8xOKMW15xx4BCUOsqw
CitedBy_id crossref_primary_10_1097_HJH_0000000000000076
crossref_primary_10_1177_1470320320919610
crossref_primary_10_1155_2020_3934212
crossref_primary_10_1007_s40292_017_0200_9
crossref_primary_10_1080_08037051_2024_2350981
crossref_primary_10_1097_HJH_0000000000000367
crossref_primary_10_1530_EJE_14_0537
crossref_primary_10_1053_j_ackd_2015_03_002
crossref_primary_10_1111_jch_13041
crossref_primary_10_1507_endocrj_EJ21_0508
crossref_primary_10_1016_j_ando_2016_02_003
crossref_primary_10_1210_clinem_dgac654
crossref_primary_10_1016_j_amjms_2016_06_015
crossref_primary_10_3389_fendo_2021_647184
crossref_primary_10_1016_j_acvd_2014_09_011
crossref_primary_10_2169_internalmedicine_3116_23
Cites_doi 10.1001/archinternmed.2007.33
10.1001/jama.295.22.2638
10.1016/j.amjhyper.2005.05.013
10.1080/10641960802443282
10.1161/HYPERTENSIONAHA.110.168484
10.1210/jc.2011-2830
10.1111/j.1440-1681.1994.tb02519.x
10.1093/ndt/gfh112
10.1097/HJH.0b013e3282f61f8c
10.2215/CJN.01060306
10.1111/j.1445-5994.1976.tb03306.x
10.1016/S0140-6736(00)04223-9
10.1016/j.amjhyper.2005.01.002
10.1161/HYPERTENSIONAHA.109.139832
10.1097/HJH.0b013e328350225d
10.1007/s11154-011-9162-8
10.1016/S0140-6736(05)74868-6
10.1016/j.jacc.2006.07.059
10.1097/00004872-200311000-00025
10.1681/ASN.2004100878
10.1097/HJH.0b013e32834666af
10.1007/s11154-011-9160-x
10.1210/jc.2004-1149
10.1210/jc.2003-031337
10.1373/clinchem.2004.041780
10.1161/01.HYP.0000230444.01215.6a
10.1161/HYPERTENSIONAHA.106.086116
10.1210/jc.2008-0104
10.1097/01.hjh.0000217857.20241.0f
10.1097/HJH.0b013e32833d2192
10.1016/j.jacc.2005.01.015
10.1161/01.HYP.0000079505.25750.11
ContentType Journal Article
Copyright Elsevier Masson SAS
2012 Elsevier Masson SAS
2014 INIST-CNRS
Copyright © 2012 Elsevier Masson SAS. All rights reserved.
Copyright_xml – notice: Elsevier Masson SAS
– notice: 2012 Elsevier Masson SAS
– notice: 2014 INIST-CNRS
– notice: Copyright © 2012 Elsevier Masson SAS. All rights reserved.
DBID 6I.
AAFTH
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1016/j.acvd.2012.07.006
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Le rapport aldostérone/rénine pour diagnostiquer un adénome de Conn : une étude multicentrique
EISSN 1875-2128
EndPage 630
ExternalDocumentID 10_1016_j_acvd_2012_07_006
23199617
26669554
S1875213612002458
1_s2_0_S1875213612002458
Genre Multicenter Study
Journal Article
GroupedDBID ---
--K
--M
.1-
.FO
.~1
0R~
0SF
1B1
1P~
1~.
1~5
23M
4.4
457
4G.
53G
5GY
5VS
6I.
6J9
7-5
71M
8P~
AACTN
AAEDT
AAEDW
AAFTH
AAFWJ
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAXKI
AAXUO
ABBQC
ABFNM
ABFRF
ABJNI
ABMAC
ABMZM
ABVKL
ABXDB
ACDAQ
ACGFO
ACGFS
ACRLP
ADBBV
ADEZE
ADMUD
ADVLN
AEBSH
AEFWE
AEKER
AENEX
AEVXI
AEXQZ
AFCTW
AFJKZ
AFKWA
AFRHN
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AIEXJ
AIKHN
AITUG
AJOXV
AJRQY
AJUYK
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
AXJTR
BAWUL
BKOJK
BLXMC
BNPGV
CS3
DIK
EBS
EFJIC
EJD
EO9
EP2
EP3
F5P
FDB
FEDTE
FIRID
FNPLU
FYGXN
GBLVA
HVGLF
HZ~
IXB
J1W
KOM
LN9
M41
MO0
N9A
NCXOZ
O-L
O9-
OAUVE
OA~
OK1
OL0
OZT
P-8
P-9
PC.
Q38
RIG
ROL
SDF
SDG
SEM
SES
SPCBC
SSH
SSZ
T5K
UNMZH
Z5R
~G-
AAIAV
ABLVK
ABYKQ
AJBFU
EFLBG
LCYCR
AALMO
ABPIF
ABQIS
ADALY
IPNFZ
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c507t-95afa23fea18768e618eaae9f0806556217023a139330496b47bde59f7cebc783
IEDL.DBID IXB
ISSN 1875-2136
IngestDate Fri Oct 25 06:16:57 EDT 2024
Thu Sep 26 19:52:08 EDT 2024
Sat Sep 28 08:00:11 EDT 2024
Thu Nov 24 18:26:35 EST 2022
Fri Feb 23 02:20:48 EST 2024
Tue Oct 15 22:54:14 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 12
Keywords Hypertension
computed tomography
ARR
blood pressure
Adénome de Conn
Aldosterone-producing adenoma
ROC
Aldosterone
BP
CT
PA
APA
Renin
Hypokalaemia
Hypokaliémie
adrenal venous sampling
Rapport aldostérone-rénine
primary aldosteronism
Aldosteronism
Aldosterone-to-renin ratio
receiver operating characteristic
Rénine
AVS
Endocrinopathy
Hydroelectrolytic balance disorder
Adrenal cortex diseases
Enzyme
Cardiovascular disease
Hyperadrenocorticism
Adenoma
Inorganic element
Peptidases
Metabolic disorder
Conn syndrome
Adrenal gland diseases
Hydrolases
Aspartic endopeptidases
Hypokaliemia
Ratio
Benign neoplasm
Diagnosis
Cardiology
Potassium
Language English
License http://www.elsevier.com/open-access/userlicense/1.0
CC BY 4.0
Copyright © 2012 Elsevier Masson SAS. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c507t-95afa23fea18768e618eaae9f0806556217023a139330496b47bde59f7cebc783
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.sciencedirect.com/science/article/pii/S1875213612002458
PMID 23199617
PQID 1221850344
PQPubID 23479
PageCount 8
ParticipantIDs proquest_miscellaneous_1221850344
crossref_primary_10_1016_j_acvd_2012_07_006
pubmed_primary_23199617
pascalfrancis_primary_26669554
elsevier_sciencedirect_doi_10_1016_j_acvd_2012_07_006
elsevier_clinicalkeyesjournals_1_s2_0_S1875213612002458
PublicationCentury 2000
PublicationDate 2012-12-01
PublicationDateYYYYMMDD 2012-12-01
PublicationDate_xml – month: 12
  year: 2012
  text: 2012-12-01
  day: 01
PublicationDecade 2010
PublicationPlace Amsterdam
PublicationPlace_xml – name: Amsterdam
– name: Netherlands
PublicationTitle Archives of cardiovascular diseases
PublicationTitleAlternate Arch Cardiovasc Dis
PublicationYear 2012
Publisher Elsevier Masson SAS
Elsevier
Publisher_xml – name: Elsevier Masson SAS
– name: Elsevier
References Rossi (bib0135) 2011; 12
Catena, Colussi, Nadalini (bib0040) 2008; 168
Niizuma, Nakahama, Kamide (bib0090) 2008; 30
Kaplan (bib0140) 2011; 12
Rossi, Barisa, Belfiore (bib0125) 2010; 28
Gordon, Stowasser, Tunny (bib0015) 1994; 21
Rossi, Barisa, Allolio (bib0160) 2012; 97
Mulatero, Stowasser, Loh (bib0030) 2004; 89
Rossi, Bernini, Desideri (bib0060) 2006; 48
Schwartz, Turner (bib0105) 2005; 51
Calhoun (bib0070) 2006; 1
Tiu, Choi, Shek (bib0110) 2005; 90
Mosso, Carvajal, Gonzalez (bib0075) 2003; 42
Sechi, Novello, Lapenna (bib0065) 2006; 295
Plouin, Amar, Chatellier (bib0100) 2004; 19
Giacchetti, Ronconi, Lucarelli (bib0085) 2006; 24
Dunn, Espiner (bib0080) 1976; 6
Sarlon-Bartoli, Michel, Taieb (bib0155) 2011; 29
Kaplan (bib0020) 2001; 357
Funder, Carey, Fardella (bib0150) 2008; 93
Stowasser, Gordon, Gunasekera (bib0035) 2003; 21
Rossi, Bernini, Caliumi (bib0005) 2006; 48
Calhoun (bib0010) 2007; 50
Matsumura, Fujii, Oniki (bib0045) 2006; 19
Lim, Rodgers, Cardale (bib0025) 1999; 353
Vonend, Ockenfels, Gao (bib0165) 2011; 57
Kaplan (bib0115) 2005
van der Linden, Steichen, Zinzindohoue (bib0130) 2012; 30
Nishizaka, Pratt-Ubunama, Zaman (bib0095) 2005; 18
Bernini, Moretti, Orlandini (bib0120) 2008; 26
Ribstein, Du Cailar, Fesler (bib0055) 2005; 16
Rossi, Seccia, Palumbo (bib0145) 2010; 55
Milliez, Girerd, Plouin (bib0050) 2005; 45
Rossi (10.1016/j.acvd.2012.07.006_bib0160) 2012; 97
van der Linden (10.1016/j.acvd.2012.07.006_bib0130) 2012; 30
Mulatero (10.1016/j.acvd.2012.07.006_bib0030) 2004; 89
Lim (10.1016/j.acvd.2012.07.006_bib0025) 1999; 353
Plouin (10.1016/j.acvd.2012.07.006_bib0100) 2004; 19
Schwartz (10.1016/j.acvd.2012.07.006_bib0105) 2005; 51
Kaplan (10.1016/j.acvd.2012.07.006_bib0115) 2005
Matsumura (10.1016/j.acvd.2012.07.006_bib0045) 2006; 19
Kaplan (10.1016/j.acvd.2012.07.006_bib0020) 2001; 357
Milliez (10.1016/j.acvd.2012.07.006_bib0050) 2005; 45
Gordon (10.1016/j.acvd.2012.07.006_bib0015) 1994; 21
Rossi (10.1016/j.acvd.2012.07.006_bib0060) 2006; 48
Mosso (10.1016/j.acvd.2012.07.006_bib0075) 2003; 42
Niizuma (10.1016/j.acvd.2012.07.006_bib0090) 2008; 30
Dunn (10.1016/j.acvd.2012.07.006_bib0080) 1976; 6
Rossi (10.1016/j.acvd.2012.07.006_bib0005) 2006; 48
Calhoun (10.1016/j.acvd.2012.07.006_bib0010) 2007; 50
Catena (10.1016/j.acvd.2012.07.006_bib0040) 2008; 168
Sarlon-Bartoli (10.1016/j.acvd.2012.07.006_bib0155) 2011; 29
Funder (10.1016/j.acvd.2012.07.006_bib0150) 2008; 93
Rossi (10.1016/j.acvd.2012.07.006_bib0125) 2010; 28
Calhoun (10.1016/j.acvd.2012.07.006_bib0070) 2006; 1
Stowasser (10.1016/j.acvd.2012.07.006_bib0035) 2003; 21
Sechi (10.1016/j.acvd.2012.07.006_bib0065) 2006; 295
Kaplan (10.1016/j.acvd.2012.07.006_bib0140) 2011; 12
Vonend (10.1016/j.acvd.2012.07.006_bib0165) 2011; 57
Nishizaka (10.1016/j.acvd.2012.07.006_bib0095) 2005; 18
Ribstein (10.1016/j.acvd.2012.07.006_bib0055) 2005; 16
Rossi (10.1016/j.acvd.2012.07.006_bib0145) 2010; 55
Bernini (10.1016/j.acvd.2012.07.006_bib0120) 2008; 26
Rossi (10.1016/j.acvd.2012.07.006_bib0135) 2011; 12
Giacchetti (10.1016/j.acvd.2012.07.006_bib0085) 2006; 24
Tiu (10.1016/j.acvd.2012.07.006_bib0110) 2005; 90
References_xml – volume: 57
  start-page: 990
  year: 2011
  end-page: 995
  ident: bib0165
  article-title: Adrenal venous sampling: evaluation of the German Conn's registry
  publication-title: Hypertension
  contributor:
    fullname: Gao
– volume: 357
  start-page: 953
  year: 2001
  end-page: 954
  ident: bib0020
  article-title: Cautions over the current epidemic of primary aldosteronism
  publication-title: Lancet
  contributor:
    fullname: Kaplan
– volume: 30
  start-page: 640
  year: 2008
  end-page: 647
  ident: bib0090
  article-title: The cut-off value of aldosterone-to-renin ratio for the diagnosis of primary aldosteronism in patients taking antihypertensive medicine
  publication-title: Clin Exp Hypertens
  contributor:
    fullname: Kamide
– volume: 97
  start-page: 1606
  year: 2012
  end-page: 1614
  ident: bib0160
  article-title: The Adrenal Vein Sampling International Study (AVIS) for identifying the major subtypes of primary aldosteronism
  publication-title: J Clin Endocrinol Metab
  contributor:
    fullname: Allolio
– volume: 19
  start-page: 774
  year: 2004
  end-page: 777
  ident: bib0100
  article-title: Trends in the prevalence of primary aldosteronism, aldosterone-producing adenomas, and surgically correctable aldosterone-dependent hypertension
  publication-title: Nephrol Dial Transplant
  contributor:
    fullname: Chatellier
– volume: 21
  start-page: 315
  year: 1994
  end-page: 318
  ident: bib0015
  article-title: High incidence of primary aldosteronism in 199 patients referred with hypertension
  publication-title: Clin Exp Pharmacol Physiol
  contributor:
    fullname: Tunny
– volume: 45
  start-page: 1243
  year: 2005
  end-page: 1248
  ident: bib0050
  article-title: Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism
  publication-title: J Am Coll Cardiol
  contributor:
    fullname: Plouin
– volume: 26
  start-page: 981
  year: 2008
  end-page: 988
  ident: bib0120
  article-title: Plasma and urine aldosterone to plasma renin activity ratio in the diagnosis of primary aldosteronism
  publication-title: J Hypertens
  contributor:
    fullname: Orlandini
– volume: 6
  start-page: 131
  year: 1976
  end-page: 135
  ident: bib0080
  article-title: Outpatient screening tests for primary aldosteronism
  publication-title: Aust N Z J Med
  contributor:
    fullname: Espiner
– volume: 90
  start-page: 72
  year: 2005
  end-page: 78
  ident: bib0110
  article-title: The use of aldosterone-renin ratio as a diagnostic test for primary hyperaldosteronism and its test characteristics under different conditions of blood sampling
  publication-title: J Clin Endocrinol Metab
  contributor:
    fullname: Shek
– volume: 295
  start-page: 2638
  year: 2006
  end-page: 2645
  ident: bib0065
  article-title: Long-term renal outcomes in patients with primary aldosteronism
  publication-title: JAMA
  contributor:
    fullname: Lapenna
– volume: 50
  start-page: 447
  year: 2007
  end-page: 453
  ident: bib0010
  article-title: Is there an unrecognized epidemic of primary aldosteronism?
  publication-title: Pro Hypertens
  contributor:
    fullname: Calhoun
– volume: 55
  start-page: 83
  year: 2010
  end-page: 89
  ident: bib0145
  article-title: Within-patient reproducibility of the aldosterone: renin ratio in primary aldosteronism
  publication-title: Hypertension
  contributor:
    fullname: Palumbo
– volume: 48
  start-page: 2293
  year: 2006
  end-page: 2300
  ident: bib0005
  article-title: A prospective study of the prevalence of primary aldosteronism in 1125 hypertensive patients
  publication-title: J Am Coll Cardiol
  contributor:
    fullname: Caliumi
– volume: 48
  start-page: 232
  year: 2006
  end-page: 238
  ident: bib0060
  article-title: Renal damage in primary aldosteronism: results of the PAPY Study
  publication-title: Hypertension
  contributor:
    fullname: Desideri
– volume: 89
  start-page: 1045
  year: 2004
  end-page: 1050
  ident: bib0030
  article-title: Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents
  publication-title: J Clin Endocrinol Metab
  contributor:
    fullname: Loh
– volume: 21
  start-page: 2149
  year: 2003
  end-page: 2157
  ident: bib0035
  article-title: High rate of detection of primary aldosteronism, including surgically treatable forms, after ‘non-selective’ screening of hypertensive patients
  publication-title: J Hypertens
  contributor:
    fullname: Gunasekera
– volume: 12
  start-page: 27
  year: 2011
  end-page: 36
  ident: bib0135
  article-title: Diagnosis and treatment of primary aldosteronism
  publication-title: Rev Endocr Metab Disord
  contributor:
    fullname: Rossi
– volume: 30
  start-page: 761
  year: 2012
  end-page: 769
  ident: bib0130
  article-title: Blood pressure and medication changes following adrenalectomy for unilateral primary aldosteronism: a follow-up study
  publication-title: J Hypertens
  contributor:
    fullname: Zinzindohoue
– volume: 18
  start-page: 805
  year: 2005
  end-page: 812
  ident: bib0095
  article-title: Validity of plasma aldosterone-to-renin activity ratio in African American and white subjects with resistant hypertension
  publication-title: Am J Hypertens
  contributor:
    fullname: Zaman
– volume: 353
  start-page: 40
  year: 1999
  ident: bib0025
  article-title: Potentially high prevalence of primary aldosteronism in a primary-care population
  publication-title: Lancet
  contributor:
    fullname: Cardale
– volume: 1
  start-page: 1039
  year: 2006
  end-page: 1045
  ident: bib0070
  article-title: Aldosteronism and hypertension
  publication-title: Clin J Am Soc Nephrol
  contributor:
    fullname: Calhoun
– volume: 51
  start-page: 386
  year: 2005
  end-page: 394
  ident: bib0105
  article-title: Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity
  publication-title: Clin Chem
  contributor:
    fullname: Turner
– volume: 29
  start-page: 1196
  year: 2011
  end-page: 1202
  ident: bib0155
  article-title: Adrenal venous sampling is crucial before an adrenalectomy whatever the adrenal-nodule size on computed tomography
  publication-title: J Hypertens
  contributor:
    fullname: Taieb
– year: 2005
  ident: bib0115
  article-title: Primary aldosteronism
  publication-title: Kaplan's Clinical Hypertension
  contributor:
    fullname: Kaplan
– volume: 24
  start-page: 737
  year: 2006
  end-page: 745
  ident: bib0085
  article-title: Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism: need for a standardized protocol
  publication-title: J Hypertens
  contributor:
    fullname: Lucarelli
– volume: 168
  start-page: 80
  year: 2008
  end-page: 85
  ident: bib0040
  article-title: Cardiovascular outcomes in patients with primary aldosteronism after treatment
  publication-title: Arch Intern Med
  contributor:
    fullname: Nadalini
– volume: 42
  start-page: 161
  year: 2003
  end-page: 165
  ident: bib0075
  article-title: Primary aldosteronism and hypertensive disease
  publication-title: Hypertension
  contributor:
    fullname: Gonzalez
– volume: 12
  start-page: 49
  year: 2011
  end-page: 52
  ident: bib0140
  article-title: Primary aldosteronism: a contrarian view
  publication-title: Rev Endocr Metab Disord
  contributor:
    fullname: Kaplan
– volume: 28
  start-page: 1892
  year: 2010
  end-page: 1899
  ident: bib0125
  article-title: The aldosterone-renin ratio based on the plasma renin activity and the direct renin assay for diagnosing aldosterone-producing adenoma
  publication-title: J Hypertens
  contributor:
    fullname: Belfiore
– volume: 16
  start-page: 1320
  year: 2005
  end-page: 1325
  ident: bib0055
  article-title: Relative glomerular hyperfiltration in primary aldosteronism
  publication-title: J Am Soc Nephrol
  contributor:
    fullname: Fesler
– volume: 19
  start-page: 13
  year: 2006
  end-page: 18
  ident: bib0045
  article-title: Role of aldosterone in left ventricular hypertrophy in hypertension
  publication-title: Am J Hypertens
  contributor:
    fullname: Oniki
– volume: 93
  start-page: 3266
  year: 2008
  end-page: 3281
  ident: bib0150
  article-title: Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline
  publication-title: J Clin Endocrinol Metab
  contributor:
    fullname: Fardella
– volume: 168
  start-page: 80
  year: 2008
  ident: 10.1016/j.acvd.2012.07.006_bib0040
  article-title: Cardiovascular outcomes in patients with primary aldosteronism after treatment
  publication-title: Arch Intern Med
  doi: 10.1001/archinternmed.2007.33
  contributor:
    fullname: Catena
– volume: 295
  start-page: 2638
  year: 2006
  ident: 10.1016/j.acvd.2012.07.006_bib0065
  article-title: Long-term renal outcomes in patients with primary aldosteronism
  publication-title: JAMA
  doi: 10.1001/jama.295.22.2638
  contributor:
    fullname: Sechi
– volume: 19
  start-page: 13
  year: 2006
  ident: 10.1016/j.acvd.2012.07.006_bib0045
  article-title: Role of aldosterone in left ventricular hypertrophy in hypertension
  publication-title: Am J Hypertens
  doi: 10.1016/j.amjhyper.2005.05.013
  contributor:
    fullname: Matsumura
– year: 2005
  ident: 10.1016/j.acvd.2012.07.006_bib0115
  article-title: Primary aldosteronism
  contributor:
    fullname: Kaplan
– volume: 30
  start-page: 640
  year: 2008
  ident: 10.1016/j.acvd.2012.07.006_bib0090
  article-title: The cut-off value of aldosterone-to-renin ratio for the diagnosis of primary aldosteronism in patients taking antihypertensive medicine
  publication-title: Clin Exp Hypertens
  doi: 10.1080/10641960802443282
  contributor:
    fullname: Niizuma
– volume: 57
  start-page: 990
  year: 2011
  ident: 10.1016/j.acvd.2012.07.006_bib0165
  article-title: Adrenal venous sampling: evaluation of the German Conn's registry
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.110.168484
  contributor:
    fullname: Vonend
– volume: 97
  start-page: 1606
  year: 2012
  ident: 10.1016/j.acvd.2012.07.006_bib0160
  article-title: The Adrenal Vein Sampling International Study (AVIS) for identifying the major subtypes of primary aldosteronism
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2011-2830
  contributor:
    fullname: Rossi
– volume: 21
  start-page: 315
  year: 1994
  ident: 10.1016/j.acvd.2012.07.006_bib0015
  article-title: High incidence of primary aldosteronism in 199 patients referred with hypertension
  publication-title: Clin Exp Pharmacol Physiol
  doi: 10.1111/j.1440-1681.1994.tb02519.x
  contributor:
    fullname: Gordon
– volume: 19
  start-page: 774
  year: 2004
  ident: 10.1016/j.acvd.2012.07.006_bib0100
  article-title: Trends in the prevalence of primary aldosteronism, aldosterone-producing adenomas, and surgically correctable aldosterone-dependent hypertension
  publication-title: Nephrol Dial Transplant
  doi: 10.1093/ndt/gfh112
  contributor:
    fullname: Plouin
– volume: 26
  start-page: 981
  year: 2008
  ident: 10.1016/j.acvd.2012.07.006_bib0120
  article-title: Plasma and urine aldosterone to plasma renin activity ratio in the diagnosis of primary aldosteronism
  publication-title: J Hypertens
  doi: 10.1097/HJH.0b013e3282f61f8c
  contributor:
    fullname: Bernini
– volume: 1
  start-page: 1039
  year: 2006
  ident: 10.1016/j.acvd.2012.07.006_bib0070
  article-title: Aldosteronism and hypertension
  publication-title: Clin J Am Soc Nephrol
  doi: 10.2215/CJN.01060306
  contributor:
    fullname: Calhoun
– volume: 6
  start-page: 131
  year: 1976
  ident: 10.1016/j.acvd.2012.07.006_bib0080
  article-title: Outpatient screening tests for primary aldosteronism
  publication-title: Aust N Z J Med
  doi: 10.1111/j.1445-5994.1976.tb03306.x
  contributor:
    fullname: Dunn
– volume: 357
  start-page: 953
  year: 2001
  ident: 10.1016/j.acvd.2012.07.006_bib0020
  article-title: Cautions over the current epidemic of primary aldosteronism
  publication-title: Lancet
  doi: 10.1016/S0140-6736(00)04223-9
  contributor:
    fullname: Kaplan
– volume: 18
  start-page: 805
  year: 2005
  ident: 10.1016/j.acvd.2012.07.006_bib0095
  article-title: Validity of plasma aldosterone-to-renin activity ratio in African American and white subjects with resistant hypertension
  publication-title: Am J Hypertens
  doi: 10.1016/j.amjhyper.2005.01.002
  contributor:
    fullname: Nishizaka
– volume: 55
  start-page: 83
  year: 2010
  ident: 10.1016/j.acvd.2012.07.006_bib0145
  article-title: Within-patient reproducibility of the aldosterone: renin ratio in primary aldosteronism
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.109.139832
  contributor:
    fullname: Rossi
– volume: 30
  start-page: 761
  year: 2012
  ident: 10.1016/j.acvd.2012.07.006_bib0130
  article-title: Blood pressure and medication changes following adrenalectomy for unilateral primary aldosteronism: a follow-up study
  publication-title: J Hypertens
  doi: 10.1097/HJH.0b013e328350225d
  contributor:
    fullname: van der Linden
– volume: 12
  start-page: 27
  year: 2011
  ident: 10.1016/j.acvd.2012.07.006_bib0135
  article-title: Diagnosis and treatment of primary aldosteronism
  publication-title: Rev Endocr Metab Disord
  doi: 10.1007/s11154-011-9162-8
  contributor:
    fullname: Rossi
– volume: 353
  start-page: 40
  year: 1999
  ident: 10.1016/j.acvd.2012.07.006_bib0025
  article-title: Potentially high prevalence of primary aldosteronism in a primary-care population
  publication-title: Lancet
  doi: 10.1016/S0140-6736(05)74868-6
  contributor:
    fullname: Lim
– volume: 48
  start-page: 2293
  year: 2006
  ident: 10.1016/j.acvd.2012.07.006_bib0005
  article-title: A prospective study of the prevalence of primary aldosteronism in 1125 hypertensive patients
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2006.07.059
  contributor:
    fullname: Rossi
– volume: 21
  start-page: 2149
  year: 2003
  ident: 10.1016/j.acvd.2012.07.006_bib0035
  article-title: High rate of detection of primary aldosteronism, including surgically treatable forms, after ‘non-selective’ screening of hypertensive patients
  publication-title: J Hypertens
  doi: 10.1097/00004872-200311000-00025
  contributor:
    fullname: Stowasser
– volume: 16
  start-page: 1320
  year: 2005
  ident: 10.1016/j.acvd.2012.07.006_bib0055
  article-title: Relative glomerular hyperfiltration in primary aldosteronism
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2004100878
  contributor:
    fullname: Ribstein
– volume: 29
  start-page: 1196
  year: 2011
  ident: 10.1016/j.acvd.2012.07.006_bib0155
  article-title: Adrenal venous sampling is crucial before an adrenalectomy whatever the adrenal-nodule size on computed tomography
  publication-title: J Hypertens
  doi: 10.1097/HJH.0b013e32834666af
  contributor:
    fullname: Sarlon-Bartoli
– volume: 12
  start-page: 49
  year: 2011
  ident: 10.1016/j.acvd.2012.07.006_bib0140
  article-title: Primary aldosteronism: a contrarian view
  publication-title: Rev Endocr Metab Disord
  doi: 10.1007/s11154-011-9160-x
  contributor:
    fullname: Kaplan
– volume: 90
  start-page: 72
  year: 2005
  ident: 10.1016/j.acvd.2012.07.006_bib0110
  article-title: The use of aldosterone-renin ratio as a diagnostic test for primary hyperaldosteronism and its test characteristics under different conditions of blood sampling
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2004-1149
  contributor:
    fullname: Tiu
– volume: 89
  start-page: 1045
  year: 2004
  ident: 10.1016/j.acvd.2012.07.006_bib0030
  article-title: Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2003-031337
  contributor:
    fullname: Mulatero
– volume: 51
  start-page: 386
  year: 2005
  ident: 10.1016/j.acvd.2012.07.006_bib0105
  article-title: Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity
  publication-title: Clin Chem
  doi: 10.1373/clinchem.2004.041780
  contributor:
    fullname: Schwartz
– volume: 48
  start-page: 232
  year: 2006
  ident: 10.1016/j.acvd.2012.07.006_bib0060
  article-title: Renal damage in primary aldosteronism: results of the PAPY Study
  publication-title: Hypertension
  doi: 10.1161/01.HYP.0000230444.01215.6a
  contributor:
    fullname: Rossi
– volume: 50
  start-page: 447
  year: 2007
  ident: 10.1016/j.acvd.2012.07.006_bib0010
  article-title: Is there an unrecognized epidemic of primary aldosteronism?
  publication-title: Pro Hypertens
  doi: 10.1161/HYPERTENSIONAHA.106.086116
  contributor:
    fullname: Calhoun
– volume: 93
  start-page: 3266
  year: 2008
  ident: 10.1016/j.acvd.2012.07.006_bib0150
  article-title: Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2008-0104
  contributor:
    fullname: Funder
– volume: 24
  start-page: 737
  year: 2006
  ident: 10.1016/j.acvd.2012.07.006_bib0085
  article-title: Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism: need for a standardized protocol
  publication-title: J Hypertens
  doi: 10.1097/01.hjh.0000217857.20241.0f
  contributor:
    fullname: Giacchetti
– volume: 28
  start-page: 1892
  year: 2010
  ident: 10.1016/j.acvd.2012.07.006_bib0125
  article-title: The aldosterone-renin ratio based on the plasma renin activity and the direct renin assay for diagnosing aldosterone-producing adenoma
  publication-title: J Hypertens
  doi: 10.1097/HJH.0b013e32833d2192
  contributor:
    fullname: Rossi
– volume: 45
  start-page: 1243
  year: 2005
  ident: 10.1016/j.acvd.2012.07.006_bib0050
  article-title: Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2005.01.015
  contributor:
    fullname: Milliez
– volume: 42
  start-page: 161
  year: 2003
  ident: 10.1016/j.acvd.2012.07.006_bib0075
  article-title: Primary aldosteronism and hypertensive disease
  publication-title: Hypertension
  doi: 10.1161/01.HYP.0000079505.25750.11
  contributor:
    fullname: Mosso
SSID ssj0062776
Score 2.0747585
Snippet Summary Background Biological diagnostic criteria for diagnosing aldosterone-producing adenoma (APA) are not well-established. Aim The aim of the study was to...
Biological diagnostic criteria for diagnosing aldosterone-producing adenoma (APA) are not well-established. The aim of the study was to establish the best...
BACKGROUNDBiological diagnostic criteria for diagnosing aldosterone-producing adenoma (APA) are not well-established.AIMThe aim of the study was to establish...
SourceID proquest
crossref
pubmed
pascalfrancis
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 623
SubjectTerms Adenoma - blood
Adenoma - diagnosis
Adenoma - metabolism
Adrenal Gland Neoplasms - blood
Adrenal Gland Neoplasms - diagnosis
Adrenal Gland Neoplasms - metabolism
Adrenals. Adrenal axis. Renin-angiotensin system (diseases)
Adénome de Conn
Aldosterone
Aldosterone - biosynthesis
Aldosterone - blood
Aldosterone-producing adenoma
Aldosterone-to-renin ratio
Aldosteronism
Arterial hypertension. Arterial hypotension
Atherosclerosis (general aspects, experimental research)
Biological and medical sciences
Blood and lymphatic vessels
Cardiology. Vascular system
Cardiovascular
Endocrinopathies
Female
Humans
Hypertension
Hypokalaemia
Hypokaliémie
Internal Medicine
Male
Medical sciences
Middle Aged
Non tumoral diseases. Target tissue resistance. Benign neoplasms
Prospective Studies
Rapport aldostérone-rénine
Renin
Renin - blood
Rénine
Title Aldosterone-to-renin ratio for diagnosing aldosterone-producing adenoma: A multicentre study
URI https://www.clinicalkey.es/playcontent/1-s2.0-S1875213612002458
https://dx.doi.org/10.1016/j.acvd.2012.07.006
https://www.ncbi.nlm.nih.gov/pubmed/23199617
https://search.proquest.com/docview/1221850344
Volume 105
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ZS8NAEB48QAQRb-NRVvBN1nZzbBrfalHqVR88KCIsm2QDFU2LrT76253ZJB6IPvhUEjbtMJPM9zXzzSzALnLwBIE94PhPx3A_S2OudTPmbkJFLkRsKahR-KIrOzf-aS_oTUC76oUhWWWZ-4ucbrN1eaZeerM-7PfrVwKptis8hGhbP6SGXy8Qtomvd1hlY-mGdoM5Wsxpddk4U2i8dPJK00LpfSBNMpS_gdPcUI_QZVmx18XvZNSC0vECzJdskrUKgxdhwuRLMHNR1suX4b71mFIXx_MgN3w84CSty5kNOkO2ytJCaIfwxfSXlUM7BtaexbQ0eNIHrMWs9NBqOQ2zQ2lX4Ob46Lrd4eV-CjxB1jfmUaAz7XqZ0egN2TRSNI3WJsoaVF1FIiRCRHCNnJBeckQy9sM4NUGUhYmJMXbeKkzlaMU6MAx9w-gojhBi_Wbq4hd5yEQasZ9mXmg8B_YqR6phMTZDVXqyB0VuV-R21aDqt3QgrHytqoZQTGFmVD5PIyXUCBerHzF3IPi48tttoxAR_vzF2reQfhiJfEVGSLEc2KlirPCBoyqKzs3gBU1xkRUFNCnRgbUi-J9XeyTqFuHGP83ahFk6KuQyWzA1fn4x20h6xnENJvffRA2mW4e3Z-f0eXLW6dbsvY5H3Xbv8u4dIZcEyw
link.rule.ids 315,783,787,3513,4509,24128,27581,27936,27937,45597,45675,45691,45886
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ZS8QwEB48QAURb-sZwTcJu73S1rdFlPXYfXEFH4SQtimsaHfZw9_vTJqqi-iDr23SDjPNzNfMNxOAM8TgGQb2kOOfjuZBkadcqTjlXkZJLozYwqVC4U5XtB-D26fwaQ4u61oYolVa31_5dOOt7ZWG1WZj2O83HlyE2p7rY4g2-cN4Hhbx2QmuzsXWzV27Wztk4UXmjDkaz2mCrZ2paF4qe6eGobQlSM0MxW_xaXWoxqi1ojru4nc8auLS9TqsWUDJWpXMGzCny01Y6tiU-RY8t15zKuQYDUrNJwNO7LqSGbszBKwsr7h2GMGY-jZyaDrBmqvomQZv6oK1mGEfGjqnZqYv7TY8Xl_1LtvcHqnAMwR-E56EqlCeX2iF2hCxFm6sldJJ0aQEK2IhN8IgrhAW0j5HItIgSnMdJkWU6RTN5-_AQolS7AFD6ze1StIEo2wQ5x4-yEcw0kyDvPAj7TtwXitSDqvOGbKmlL1IUrsktcsmJcCFA1Gta1nXhKIX02O7pMbSlWMcLH-Y3YHwc-bMlyMxKPz5xuMZk34KiZBFJIiyHDitbSxxzVEiRZV6MEVRPARGITVLdGC3Mv7XbJ943W60_0-xTmC53evcy_ub7t0BrNCdij1zCAuT0VQfIQaapMf2G_8AuMwDMw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Aldosterone-to-renin+ratio+for+diagnosing+aldosterone-producing+adenoma%3A+a+multicentre+study&rft.jtitle=Archives+of+cardiovascular+diseases&rft.au=Ducher%2C+Michel&rft.au=Mounier-V%C3%A9hier%2C+Claire&rft.au=Baguet%2C+Jean-Philippe&rft.au=Tarti%C3%A8re%2C+Jean-Michel&rft.date=2012-12-01&rft.eissn=1875-2128&rft.volume=105&rft.issue=12&rft.spage=623&rft_id=info:doi/10.1016%2Fj.acvd.2012.07.006&rft_id=info%3Apmid%2F23199617&rft.externalDocID=23199617
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F18752136%2FS1875213612X00111%2Fcov150h.gif